Heramed Share Price and Company Fundamentals



Price
$0.215
Change
0.010 (4.878%)
52 week
0.086 - 0.305

Last traded: Last Friday at 5:32 AM

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor principally for use by an expectant mother to monitor their fetus' heartbeat. It is also involved in developing EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.

Key Metrics

PE ratio

-

PB ratio

19.55

Dividend yield

Beta

-0.40

Market cap

$38.1M

Enterprise value

$36.15M

Company profile

Primary activitiesDevelopment, manufacture and distribution of fetal heart beat monitors and other pregnancy-related solutions.
Industry / SectorMedical Devices / Healthcare
Websitehttp://www.hera-med.com
Mailing address6 Meir Ariel Street POB 8576 Netanya 4059300 Israel
Phone / Fax /
Share registryAUTOMIC REGISTRY SERVICES

Dividends

Heramed does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Heramed.

NameTitleAgeTotal Pay
Mr. David GrobermanCo-Founder, CEO & Exec. Director211.91k
Mr. Tal SlonimCo-Founder, COO & Exec. Director58.3k
Ms. Sivan SadanChief Financial Officer127.22k
Mr. Michael NennerChief Technology Officer
Henry JordanHead of Investor Relations
Mr. Ariel LadenVP of Marketing
Dr. Josef TovbinChief Medical Officer
Mr. Jonathan Hart B.Com., L.L.B.Company Sec.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-15,316.19%

Return on assets

-69.07%

Return on equity

-167.66%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Heramed is 38.1M and its enterprise value is 36.15M. The enterprise value to revenue ratio of HMD is 1,471.19.

Companies similar to Heramed (HMD)

Heramed (ASX:HMD) Frequently Asked Questions

1. What is Heramed's Stock Symbol?

Heramed trades on ASX under the ticker symbol "HMD".

2. What is Heramed's stock price today?

One share of HMD stock can currently be purchased for approximately $0.215.

3. How can I contact Heramed?

Heramed's mailing address is 6 Meir Ariel Street POB 8576 Netanya 4059300 Israel. The company can be reached via phone at .

4. What is Heramed's official website?

The official website of Heramed is http://www.hera-med.com.

5. Which share registry manages Heramed's stock?

Heramed's stock is managed by AUTOMIC REGISTRY SERVICES.